US Stock MarketDetailed Quotes

OCEA Ocean Biomedical

Watchlist
  • 0.664
  • +0.075+12.75%
Close Dec 20 16:00 ET
  • 0.613
  • -0.051-7.68%
Post 19:46 ET
23.12MMarket Cap-0.20P/E (TTM)

Ocean Biomedical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-849.55%-9.43M
-2,524.24%-866K
-156.24%-1.13M
-3,281.58%-5.14M
-524.80%-2.29M
5.70%-993K
76.76%-33K
26.38%-441K
22.05%-152K
-213.68%-367K
Net income from continuing operations
-559.40%-114.47M
-1,614.75%-16.86M
-284.05%-14.09M
-55.88%-11.43M
-1,241.25%-72.09M
72.16%-17.36M
87.98%-983K
24.93%-3.67M
-37.30%-7.33M
87.77%-5.38M
Operating gains losses
35,225.20%88.31M
11,137.28%63.35M
-48.51%224K
---28.99M
--53.73M
--250K
---574K
--435K
----
----
Other non cash items
1,569.43%15.51M
---44.57M
--45.57M
663.37%1.54M
4,636.13%12.98M
--929K
----
----
---273K
--274K
Change In working capital
-57.96%1.18M
-304.54%-1.22M
1,212.68%1.58M
-158.80%-1.27M
994.76%2.09M
-40.75%2.81M
-82.97%595K
44.53%-142K
259.04%2.17M
-78.80%191K
-Change in prepaid assets
---519K
----
----
----
----
----
----
----
----
----
-Change in payables and accrued expense
-39.48%1.7M
-217.31%-698K
1,212.68%1.58M
-137.98%-1.27M
309.94%2.09M
--2.81M
--595K
---142K
--3.35M
---996K
-Change in other working capital
----
----
----
----
----
----
----
----
----
--1.19M
Cash from discontinued investing activities
Operating cash flow
-849.55%-9.43M
-2,524.24%-866K
-155.66%-1.13M
-3,066.89%-4.78M
-622.34%-2.65M
5.70%-993K
76.76%-33K
26.21%-442K
22.56%-151K
-213.68%-367K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
975.39%10.4M
1,812.24%839K
0
2,502.75%6.64M
387.98%2.92M
-13.12%967K
-216.67%-49K
16,300.00%162K
50.00%255K
-33.59%599K
Net issuance payments of debt
826.26%6.81M
1,470.37%740K
--0
3,047.27%5.19M
46.08%875K
--735K
---54K
--25K
--165K
--599K
Net common stock issuance
---48.51M
---50.56M
---51.61M
--52.07M
--1.58M
--0
--0
--0
--0
--0
Proceeds from stock option exercised by employees
----
----
--0
----
----
----
----
--0
----
----
Net other financing activities
22,359.05%52.11M
----
----
---52.07M
--464K
141.67%232K
-88.10%5K
4,666.67%137K
----
----
Cash from discontinued financing activities
Financing cash flow
975.39%10.4M
1,812.24%839K
--0
2,502.75%6.64M
387.98%2.92M
-13.12%967K
-216.67%-49K
16,300.00%162K
50.00%255K
-33.59%599K
Net cash flow
Beginning cash position
-43.33%34K
788.79%1.03M
447.09%2.16M
4.79%306K
-43.33%34K
--60K
-27.50%116K
-48.03%395K
-62.80%292K
--60K
Current changes in cash
3,830.77%970K
67.07%-27K
-305.02%-1.13M
1,700.97%1.86M
17.24%272K
-143.33%-26K
18.00%-82K
53.50%-279K
512.00%103K
-70.45%232K
End cash Position
2,852.94%1M
2,852.94%1M
788.79%1.03M
447.09%2.16M
4.79%306K
-43.33%34K
-43.33%34K
-27.50%116K
-48.03%395K
-62.80%292K
Free cash flow
-849.55%-9.43M
-2,524.24%-866K
-155.66%-1.13M
-3,066.89%-4.78M
-622.34%-2.65M
5.70%-993K
76.76%-33K
26.21%-442K
22.56%-151K
-213.68%-367K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -849.55%-9.43M-2,524.24%-866K-156.24%-1.13M-3,281.58%-5.14M-524.80%-2.29M5.70%-993K76.76%-33K26.38%-441K22.05%-152K-213.68%-367K
Net income from continuing operations -559.40%-114.47M-1,614.75%-16.86M-284.05%-14.09M-55.88%-11.43M-1,241.25%-72.09M72.16%-17.36M87.98%-983K24.93%-3.67M-37.30%-7.33M87.77%-5.38M
Operating gains losses 35,225.20%88.31M11,137.28%63.35M-48.51%224K---28.99M--53.73M--250K---574K--435K--------
Other non cash items 1,569.43%15.51M---44.57M--45.57M663.37%1.54M4,636.13%12.98M--929K-----------273K--274K
Change In working capital -57.96%1.18M-304.54%-1.22M1,212.68%1.58M-158.80%-1.27M994.76%2.09M-40.75%2.81M-82.97%595K44.53%-142K259.04%2.17M-78.80%191K
-Change in prepaid assets ---519K------------------------------------
-Change in payables and accrued expense -39.48%1.7M-217.31%-698K1,212.68%1.58M-137.98%-1.27M309.94%2.09M--2.81M--595K---142K--3.35M---996K
-Change in other working capital --------------------------------------1.19M
Cash from discontinued investing activities
Operating cash flow -849.55%-9.43M-2,524.24%-866K-155.66%-1.13M-3,066.89%-4.78M-622.34%-2.65M5.70%-993K76.76%-33K26.21%-442K22.56%-151K-213.68%-367K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 975.39%10.4M1,812.24%839K02,502.75%6.64M387.98%2.92M-13.12%967K-216.67%-49K16,300.00%162K50.00%255K-33.59%599K
Net issuance payments of debt 826.26%6.81M1,470.37%740K--03,047.27%5.19M46.08%875K--735K---54K--25K--165K--599K
Net common stock issuance ---48.51M---50.56M---51.61M--52.07M--1.58M--0--0--0--0--0
Proceeds from stock option exercised by employees ----------0------------------0--------
Net other financing activities 22,359.05%52.11M-----------52.07M--464K141.67%232K-88.10%5K4,666.67%137K--------
Cash from discontinued financing activities
Financing cash flow 975.39%10.4M1,812.24%839K--02,502.75%6.64M387.98%2.92M-13.12%967K-216.67%-49K16,300.00%162K50.00%255K-33.59%599K
Net cash flow
Beginning cash position -43.33%34K788.79%1.03M447.09%2.16M4.79%306K-43.33%34K--60K-27.50%116K-48.03%395K-62.80%292K--60K
Current changes in cash 3,830.77%970K67.07%-27K-305.02%-1.13M1,700.97%1.86M17.24%272K-143.33%-26K18.00%-82K53.50%-279K512.00%103K-70.45%232K
End cash Position 2,852.94%1M2,852.94%1M788.79%1.03M447.09%2.16M4.79%306K-43.33%34K-43.33%34K-27.50%116K-48.03%395K-62.80%292K
Free cash flow -849.55%-9.43M-2,524.24%-866K-155.66%-1.13M-3,066.89%-4.78M-622.34%-2.65M5.70%-993K76.76%-33K26.21%-442K22.56%-151K-213.68%-367K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
NVIDIA
NVDA
+3.08%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%

Unlock the Full List

Investment Theme Top Gainers Yesterday
Top Gainers Yesterday
Intraday-0.12%